[December 07, 2017] |
|
Australia Pharmaceutical Pricing & Reimbursement Concise Guide 2017 - Research and Markets
The "IMS
Pharmaceutical Pricing & Reimbursement Concise Guide: Australia"
report has been added to Research and Markets' offering.
The Pharmaceutical Pricing & Reimbursement Concise Guides are
established as the definitive reference and training text for P&R
professionals around the world, drawing on the long-standing expertise
of the IMS pricing and reimbursement specialists to provide industry
players and decision makers with a thorough understanding of the rules
and regulations governing P&R in international markets.
This report covers key developments in P&R, market access, cost
containment, trade margins and healthcare issues.
Key Topics Covered:
1. Healthcare System
-
Facts & Figures
-
Market Indicators
-
Provision & Funding
-
Private Insurance
-
Healthcare Services
2. Pricing
-
Prescription Drugs
-
Pricing Procedure
-
Pricing Mechanisms
-
Background
-
Generic Drugs
-
Hospital Drugs
-
OTC Drugs
3. Reimbursement
-
Admission to Reimbursement
-
Application Process
-
Listing Recommendations
-
PBAC Reform
-
Formularies
-
Reimbursement Restrictions
-
Reimbursement Categories
-
Reimbursement Prices
-
Hospital Reimbursement
-
Formularies
-
Funding
-
Changes in Reimbursement Status
-
Minor Submissions
-
Major Submissions
-
Other Changes
-
Post-market Reviews
-
Delisting of OTCs
-
Changes in Reimbursement Prices
-
Price Adjustments
-
Price Reviews
-
Price Cuts
-
Price Disclosure
4. Pharmacoeconomics
-
Pharmacoeconomic Requirements
-
Pharmaceutical Benefits Scheme
-
Hospital Formularies
5. Price Build Up
-
Wholesalers
-
Mark-ups
-
CSO Funding Pool
-
Background
-
Retail Pharmacies
-
Margins
-
Background
-
Dispensing Doctors
-
Sales Tax
6. Cost Containment
-
Industry Paybacks
-
Promotional Costs
-
Expenditure
-
Controls over Advertising and Promotion
-
Patient Co-payments
-
Healthcare
-
Prescribing Controls
-
National Prescribing Service
-
Hospital Prescribing
-
Reimbursement Restrictions
-
E-Health
-
Generics
-
Substitution
-
Sustainability Initiative
-
INN Prescribing
-
Rx-to-OTC Switches
-
Procedure for Switching
-
Recent Switches
-
Other Changes of Status
-
OTC Market
-
Parallel Trade
7. Future Developments
-
Outlook
-
Healthcare System
-
PBS Medicine Package 2017
-
Wholesalers and Retail Pharmacies
-
Review of Pharmacy Remuneration and Location
-
Advertising of Schedule 3 Medicines
8. Names & Addresses
For more information about this report visit https://www.researchandmarkets.com/research/zpz5dd/ims
View source version on businesswire.com: http://www.businesswire.com/news/home/20171207005627/en/
[ Back To TMCnet.com's Homepage ]
|